St. Joseph’s Companion Aspirin
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer & Specialty Pharmaceuticals introduces specially packaged St. Joseph's aspirin for consumers to take in the event of a suspected heart attack, the firm announces Aug. 23. Companion Aspirin, which began shipping in July, includes three individual packets, each containing two chewable tablets of aspirin 81 mg. Each individual packet provides the "emergency" dose recommended at onset of heart attack symptoms in an easy-to-open pouch and will retail for $1.00, McNeil notes. FDA approved modified labeling for aspirin in 1998, allowing language recommending aspirin use during suspected acute myocardial infarction (1"The Tan Sheet" Oct. 26, 1998, p. 4)...
You may also be interested in...
Aspirin Professional Indications Add Use During Acute MI In FDA Final Rule
FDA's final rule on professional labeling for aspirin includes an indication for aspirin use during suspected acute myocardial infarction as soon as a heart attack is suspected, as directed by health care personnel.
Biogen ‘Ready To Launch’ Aducanumab If It Gets The Chance
The company has identified 600 sites of care to treat Alzheimer's patients with aducanumab in the US and is confident on its pricing strategy, management said.
Intuitive Exceeds Expectations In Q1 As Da Vinci Sales And Surgeries Recover
The robotic surgery company recorded $1.29bn in first-quarter revenue, an 18% year-over-year increase. Worldwide da Vinci procedures were up 16% as surgical volumes recovered from the pandemic.